Book Value per Share: Alterity Therapeutics (ATHE)

Alterity Therapeutics Limited (ATHE) - corporate logo

Alterity Therapeutics (ATHE) aims to halt cellular senescence through innovative metal binding in the brain. Diversification of the small molecule pipeline reduces regulatory risks, and patent protection will be fully established following final tests. The book value per share illustrates capital dynamics, where 1.62 reflects the latest metric value, confirming the current financial stability of the pre-commercial business.

Alterity Therapeutics Ltd (ATHE) Equity per Share: for the period 07/04/2022 - 10/28/2026

Alterity Therapeutics Ltd. - analytical breakdowns and key metrics (ATHE)

- price and consensus price forecast:
Stock Price Alterity Therapeutics Ltd|ATHE - Fair Value Consensus
- market capitalization data:
Market Capitalization Alterity Therapeutics Limited|ATHE - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Alterity Therapeutics|ATHE - Accounting Capitalization|Market Capitalization to Book Value Ratio alteritytherapeutics.com|ATHE - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Alterity Therapeutics|ATHE - Long-Term Debt to Capital|Short-Term Debt to Equity Alterity Therapeutics Ltd|ATHE - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Alterity Therapeutics Limited
Fundamental company valuation:alteritytherapeutics.com, ATHE
Manufactured products of Alterity Therapeutics Ltd

Book value per share represents the difference between all of the issuer's assets and liabilities divided by the number of securities, which determines the actual value of the owner's stake. Analyzing the equity per share is critically important for Alterity Therapeutics (ATHE), as the lack of revenue and the risks of trial failure make this indicator the sole measure of financial stability in the face of potential bankruptcy.

Competitors of Alterity Therapeutics (ATHE)

Book Value per Share Biogen Corp (BIIB)|NBIX - Accounting Value of a Share|Book Value per Share RGC|AXSM (axsome.com) - Net Asset Value per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Trevi Corp (TRVI) - Net Asset Value per Share|PRAX (Praxis Precision Medicines) - Book Value per Share|Book Value per Share AVXL|Net Assets per Single Share CeriBell (CBLL)|Net Assets per Single Share Prothena Corporation PRTA|Accounting Value per Share Alector (ALEC)|Book Price of a Share Annexon Biosciences Inc. ANNX|OMER (Omeros Corp.) - Book Value per Share|NGNE: Net Asset Value per Share|Net Assets per Single Share AC Immune SA ACIU|Voyager Therapeutics Inc (VYGR) - Accounting Value of a Share|NMRA: Book Value per Share|Net Assets per Share Scilex Holding Company, Inc. (SCLX)|Accounting Value per Share Tevogen Bio Holdings|Book Price of a Share alphacognition.com ACOG|CGTX: Accounting Value per Share|IKT - Net Asset Value per Share|Accounting Value per Share Cassava (SAVA)|Assertio Holdings, Inc. (ASRT) - Accounting Value of a Share|COYA - Accounting Value per Share|Vistagen (VTGN) - Book Price of a Share|OVID - Book Value per Share|Accounting Value of a Share Acumen Pharmaceuticals Inc.|CervoMed Inc - Book Value per Share|Net Asset Value per Share CLNN (clene.com)|Net Assets per Single Share PepGen|Accounting Value of a Share Jupiter Neurosciences, Inc. JUNS|Relmada Therapeutics, Inc. - Book Value per Share|ANVS: Book Value per Share|Net Assets per Single Share gracetx.com (GRCE)|Firefly Neuro (AIFF) - Share Book Value|Book Value per Share KLTO (ANEW Medical)|Net Asset Value per Share NeuroSense Therapeutics, Ltd. (NRSN)|Accounting Value per Share RVPH|Book Value per Share metaviatx.com MTVA|Accounting Value per Share NeurAxis, Inc (NRXS)|Book Price of a Share Helius Medical Technologies, Inc. HSDT|Book Value per Share PASG (Passage Bio Corp)|NEUP - Net Assets per Share|NERV (Minerva Neurosciences, Inc.) - Book Value per Share|ATHA (Athira Pharma Inc) - Accounting Value per Share|ADXN: Net Assets per Single Share|Net Assets per Share Alzamend|Book Value per Share CYCN|Book Value per Share protagenic.com PTIX|Accounting Value per Share Pasithea Therapeutics Corp. (KTTA)|Book Price of a Share Cortigent Inc CRGT|Book Value per Share Avenue Therapeutics, Inc (ATXI)|BCLI - Accounting Value of a Share|Book Value per Share CARA|CHRO (chromocell.com) - Net Asset Value per Share|Net Assets per Single Share Eliem Therapeutics, Inc. (ELYM)|Equity per Share Intra-Cellular|Longboard Pharma - Book Value per Share|Net Asset Value per Share Marinus Pharma MRNS|Accounting Value per Share NKGN (NKGen Biotech, Inc.)|neurobopharma.com - Book Value per Share|Net Assets per Single Share Sage Therapeutics (SAGE)|SNPX: Accounting Value of a Share|Net Assets per Single Share TRVN|Vigil Neuroscience, Inc. (VIGL) - Net Asset Value per Share|WENA (Anew Medical) - Book Value per Share|Book Value per Share CERE